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Abstract Thyroid cancer is one of the major health
concerns after the accident in the Fukushima Dai-ichi
nuclear power station (NPS). Currently, ultrasonography
surveys are being performed for persons residing in the
Fukushima Prefecture at the time of the accident with an
age of up to 18 years. Here, the expected thyroid cancer
prevalence in the Fukushima Prefecture is assessed based
on an ultrasonography survey of Ukrainians, who were
exposed at an age of up to 18 years to 131I released during
the Chernobyl NPS accident, and on differences in equip-
ment and study protocol in the two surveys. Radiation risk
of thyroid cancer incidence among survivors of the atomic
bombings of Hiroshima and Nagasaki and preliminary
estimates of thyroid dose due to the Fukushima accident
were used for the prediction of baseline and radiation-
related thyroid cancer risks. We estimate a prevalence of
thyroid cancer of 0.027 % (95 % CI 0.010 %; 0.050 %) for
the first screening campaign in the Fukushima Prefecture.
Compared with the incidence rate in Japan in 2007, the
ultrasonography survey is predicted to increase baseline
thyroid cancer incidence by a factor of 7.4 (95 % CI 0.95;
17.3). Under the condition of continued screening, thyroid
cancer during the first fifty years after the accident is pre-
dicted to be detected for about 2 % of the screened popu-
lation. The prediction of radiation-related thyroid cancer in
the most exposed fraction (a few ten thousand persons) of
the screened population of the Fukushima Prefecture has a
large uncertainty with the best estimates of the average risk
of 0.1–0.3 %, depending on average dose.
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Introduction
Large amounts of radionuclides were released from the
Fukushima Dai-ichi nuclear power station (NPS) in the
aftermath of the 2011 Great East Japan earthquake, tsunami
and reactor accident. Thanks to prompt actions of Japanese
authorities, radiation exposures of the population were
generally low. However, average thyroid doses of young
children in some settlements were reported to be of the
order of or even exceeding 100 mSv (WHO 2013). These
dose estimates are based on measurements on environ-
mental and food samples (WHO 2012). In contrast, mea-
surements of incorporated 131I indicate that thyroid doses
in the population were lower than the WHO estimate
(Kamada et al. 2012; Tokonami et al. 2012; Kim et al.
2013; Matsuda et al. 2013).
There is concern about thyroid cancer induced by the
accident at the Fukushima Dai-ichi NPS. The concern is
caused by the massive increase in thyroid cancer among
those who were highly exposed during childhood due to the
Chernobyl accident (Kazakov et al. 1992; UNSCEAR
2011). In order to monitor thyroid cancer, periodic thyroid
ultrasonography surveys have been introduced for all
inhabitants of the Fukushima Prefecture who were 18 years
old or younger at the time of the accident (Fukushima
Medical University 2013a).
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Thyroid cancer is a rare disease, although thyroid cancer
incidence has increased worldwide during the previous
decades. This increase might be related to improved
diagnostics. No evidence for an influence of stable iodine
supply could be demonstrated in a Danish study comparing
thyroid cancer incidence before and after iodine supple-
mentation (Bloomberg et al. 2012). Ultrasonography has a
large potential of detecting so-called occult carcinoma that
do not become clinically relevant during lifetime (Welch
and Black 2010; Moynihan et al. 2012). The existence of
such carcinoma has been demonstrated by autopsies with
prevalence values ranging from 1.5 % in Greece (Delides
et al. 1987) to 36 % in Finland (Harach et al. 1985). Dif-
ferent definitions of prevalence are given in the literature.
In the present paper, ‘proportion of a population that has a
disease at a specific point in time’ is used as a definition
(Rothmann and Greenland 1998). In contrast, incidence
rate is defined as number of new cases reported per year
and per number of persons in the population under
continuing practices of detection and reporting. Thus, the
first campaign of the new programme of ultrasonography
surveys yields the prevalence of thyroid cancer, and sub-
sequent campaigns the incidence rate among people who
already participated in the first campaign.
Autopsies of 2,372 of otherwise cancer-free survivors of
the atomic bombings of Hiroshima and Nagasaki revealed
106 papillary thyroid microcarcinoma, mostly of the scle-
rosing variant (Hayashi et al. 2010). This corresponds to a
prevalence of 4.5 %. The autopsy results apply mainly to
adults. No conclusive data on occult thyroid cancer in
children are available. The number of occult carcinomas
detected by ultrasonography depends on the equipment and
study protocol used. Several other factors like the age–
gender structure of the cohort and the country-specific or
even group-specific thyroid cancer frequency influence
prevalence (first screening) and incidence rate (subsequent
screenings) in ultrasonography surveys.
As of 31 July 2013, ultrasonography has been performed
on 11 March 2011 for 41,296 children, adolescents and
young adults living in thirteen municipalities of the
Fukushima Prefecture that were targeted for screening
before April 2012 (Fukushima Medical University 2013a).
A secondary examination was required for 214 persons
with thyroid nodules larger than 5 mm or cysts larger than
20 mm. These examinations were completed for 165 per-
sons allowing a first estimation of thyroid cancer preva-
lence in the young population. Cytology of fine needle
aspiration (FNA) biopsies revealed 14 cases of suspected
malignancy. Surgery has been performed for 10 of them; 9
were identified as papillary carcinoma, one as a benign
tumour. The 13 cases of confirmed (9) or still suspected (4)
thyroid cancer correspond to a prevalence of
13/41,296 = 0.031 %. The prevalence is expected to
increase because of possible thyroid cancer cases among
the 49 persons for whom secondary examination was
required but not completed by 31 July 2013.
In a second group of municipalities that were targeted
for screening between April 2012 and March 2013,
135,586 people were screened and 30 cases of suspected
thyroid cancer were detected by cytology of FNA biopsies.
Only 55 % of the required secondary examinations were
already finished by 31 July 2013; thus, the prevalence in
these municipalities is expected to increase beyond the
present value of 0.022 %.
Ultrasonography has been performed for the UkrAm
cohort consisting of Ukrainians who were 18 years old or
younger on 26 April 1986, the date of the Chernobyl
accident (Tronko et al. 2006). Concerning sex–age distri-
bution of the cohort at the time of the accident and baseline
incidence rate (National Cancer Register of Ukraine 2013),
the cohort is comparable with the study group in the
Fukushima Prefecture. However, the first screening was
performed from 1998 to 2000, i.e. 12–14 years after
exposure. The study protocol selected nodules sized from 5
to 10 mm for secondary examination only, if further cri-
teria (such as hypoechoic nodule, or nodules with micro-
calcifications, having irregular contour or extension
through the thyroid capsule, or suspicious lymph nodes)
were fulfilled (O’Kane et al. 2010). Thus, this protocol
leads under otherwise same conditions to a smaller prev-
alence than the study protocol in the Fukushima Prefecture.
Nevertheless, prevalence of confirmed thyroid cancer cases
in the UkrAm cohort, which were assessed to be not related
to the exposure from the Chernobyl accident, was higher
than what is expected for the Fukushima Prefecture,
because cohort members at the time of the first screening
were older, in average by about 12 years.
Repeated ultrasonography was also performed for the
UkrAm cohort (Brenner et al. 2011). Comparison with the
baseline thyroid cancer incidence rate in Ukraine allows an
assessment of the impact of the screening on reported
incidence rates. The effect of an increased surveillance of
the thyroid was also analysed for Belarusian and Ukrainian
population groups (Jacob et al. 2006a; Likhtarov et al.
2006). Based on these three studies, in the present paper,
the baseline (not related to the radiation exposure due to
the accident at the Fukushima Dai-ichi NPS) thyroid cancer
incidence rate in the Fukushima Prefecture under the
conditions of ongoing surveys is estimated.
Long-term thyroid cancer risk due to exposure to
external ionizing radiation has been analysed in a number
of studies (Ron et al. 1995; Furukawa et al. 2013; Veiga
et al. 2012). However, higher thyroid doses among inhab-
itants of the Fukushima Prefecture were mainly caused by
incorporation of radioiodine (WHO 2012). For young age
at exposure to radioiodine and the first 20 years after the
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Chernobyl accident, an increased risk has been demon-
strated (Tronko et al. 2006; Brenner et al. 2011; Cardis
et al. 2005; Kopecky et al. 2006; Jacob et al. 2006b).
However, the risk information is less complete than for
external exposures. In the present study, radiation risks
from data of the atomic bomb survivors are derived and the
consistency with results obtained in studies on people
exposed to 131I from the Chernobyl nuclear power plant is
investigated. The LSS risk function is used to predict
excess rates in the Fukushima Prefecture by applying a
screening factor that is based on experiences in the UkrAm
cohort and differences in the study protocol of the ultra-
sonography surveys.
Materials and methods
Study groups, screening intervals and thyroid dose
The Fukushima Health Management Survey includes
ultrasonography of the thyroid of all residents of the
Fukushima Prefecture aged up to 18 years on 11 March
2011 (Fukushima Medical University 2013a). Based on
post-Chernobyl studies, we calculated thyroid cancer
prevalence for two campaigns of the first screening,
October 2011 to March 2012, and April 2012 to March
2013 (see Supporting Information for sex–age distribu-
tions). Prevalence is also calculated for the sex–age dis-
tribution in the ultrasonography survey of children and
adolescents in the three non-contaminated prefectures of
Aomori, Yamanashi und Nagasaki (Taniguchi et al. 2013).
According to WHO (2013), in one scenario, an average
thyroid dose of 50 mSv for the most exposed fraction (a
few ten thousand persons) of the surveyed population in the
Fukushima Prefecture is assumed here. Since measure-
ments of the iodine content indicate lower doses (Kamada
et al. 2012; Kim et al. 2013; Matsuda et al. 2013; Toko-
nami et al. 2012), however, in a second scenario, an
average thyroid dose of 20 mSv was also assumed. Note
that individual thyroid doses could have been considerably
larger or smaller. For a linear dose response, however,
excess incidence rate is determined by the average dose
and not by other parameters of the dose distribution.
Thyroid cancer prevalence detected by ultrasonography
The UkrAm cohort consists of 13,127 Ukrainians who were
up to 18 years old on 26 April 1986, the date of the
Chernobyl accident (Tronko et al. 2006). During the time
of the first screening in the UkrAm cohort, the age-stan-
dardized thyroid cancer incidence rate in Ukraine was 1.2
and 4.9 cases per 105 person-years for males and females,
respectively (National Cancer Registry of Ukraine 2013).
These rates are comparable with those in Japan in 2007 of
2.2 and 7.9 cases per 105 person-years (National Cancer
Center 2012). The first round of ultrasonography in the
UkrAm cohort was performed 12–14 years after the acci-
dent, and 45 pathologically confirmed thyroid cancer cases
were detected. Tronko et al. estimated that 11.2 (95 % CI
3.2; 22.5) of these cases would have been detected in the
absence of the exposure due to the Chernobyl accident.
This corresponds to a prevalence, PUA, of about 0.09 (95 %
CI 0.02; 0.17) %.
In the present paper, the prevalence for the population in
Fukushima Prefecture, PFp, is estimated by taking into
account differences in study protocols and sex–age struc-
tures of the screened populations (Eq. 1):
PFp ¼ fspPUAkJapan;Fp=kUkraine;U1 ð1Þ
where kJapan,Fp and kUkraine,U1 are the average incidence
rates in a hypothetical group of Japanese (National Cancer
Center 2012) with the sex–age structure of the surveyed
Fukushima population and of a hypothetical group of
Ukrainians (Fedorenko et al. 2002) with the sex–age
structure of the UkrAm cohort during the first survey,
respectively. The factor fsp accounts for differences in the
study protocols in the UkrAm study and the Fukushima
survey. The ratio of the numbers of all tumours larger than
5 mm (study protocol in the Fukushima Prefecture) and
larger than 10 mm (UkrAm cohort) under otherwise the
same conditions is the maximum of fsp, because also some
nodules in the size range from 5 to 10 mm were selected in
the UkrAm for further investigation and turned out to be
cancer (O’Kane et al. 2010).
No direct information is available to determine fsp for
tumours. As a surrogate, the corresponding ratio for nod-
ules is used instead. This choice is supported by the thyroid
screening study in Hong Kong (Yuen et al. 2011), in which
the ratio for nodules larger than 5 mm and larger than
10 mm is 2.4 (398/169). For tumours, the ratio is 2.2 (11/
5), nearly equal to that for nodules. The screenings from
October 2011 to March 2013 in the Fukushima Prefecture
detected 1,125 nodules larger than 5 mm and 354 nodules
larger than 10 mm (Fukushima Medical University 2013b).
Correspondingly, the upper boundary of fsp is estimated to
be 1,125/354 = 3.2. The lower boundary is assumed to
correspond to no additional cases according to differences
in the study protocol, 1.0. The factor fsp is assumed to have
a symmetrical triangular distribution between these two
boundaries with a maximum at 2.1.
Impact of ultrasonography and thyroid surveillance
on thyroid cancer incidence rate
The impact of the second to fourth screenings on the
incidence rate in the UkrAm cohort can be calculated as the
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ratio of the baseline incidence rate in the cohort (Brenner
et al. 2011) and the incidence rate in Ukraine in the period
2001–2007 for a hypothetical population with the same
sex–age distribution as that of the UkrAm cohort (National
Cancer Registry of Ukraine 2013). The baseline incidence
rate in the cohort can be estimated by the ratio of the excess
absolute rate per unit dose, EARUA, and the excess relative
risk per unit dose, ERRUA. Brenner et al. (2011) estimated
the EARUA to be 22.1 (95 % CI 0.04; 5.78) cases per 10
5
person-years per Gy, and the ERRUA to 1.91 (95 % CI 0.43;
6.34) Gy-1. These numbers indicate a best estimate of the
baseline incidence rate in the UkrAm cohort during the
second to fourth screening of 11.6 cases per 105 person-
years. The incidence rate in Ukraine with the same sex–age
structure as in the UkrAm cohort during the second to
fourth screening, kUkraine,U2–4, is 3.3 cases per 10
5 person-
years (National Cancer Center of Ukraine 2013). The
screening factor in the UkrAm, fUA, is calculated by
fUA ¼ EARUA=ðERRUA  kUkraine;U24Þ ð2Þ
EARUA and ERRUA are correlated, and the coefficient of
determination (square of correlation coefficient) has been
assumed to be uniformly distributed from 0.7 to 1.0.
Thus, the distribution of the screening factor in the
Fukushima Prefecture, Fscr, is a product of the screening
factor in the UkrAm cohort, fUA, and the factor taking into
account differences in the study protocol, fsp.
Thyroid cancer risk in LSS
Recently, thyroid cancer risk in the cohort of survivors of
the atomic bombings of Hiroshima and Nagasaki has been
analysed by Furukawa et al. (2013) in the frame of the so-
called Life Span Study, (LSS). Their analysis excluded
microcarcinoma (tumours smaller than 10 mm). However,
tumours smaller than 10 mm are expected to contribute
significantly to thyroid cancer prevalence and incidence
rate in the Fukushima Prefecture under the conditions of
ultrasonography surveys. An earlier analysis of thyroid
cancer in the LSS by Preston et al. (2007) included mi-
crocarcinoma, but did not provide separate risks for LSS
members participating or not participating in screening in
the adult health study (AHS) where participants are med-
ically examined every second year. In order to take into
account both effects, i.e. those of carcinoma of size smaller
than 10 mm and those of increased thyroid surveillance in
the AHS, we re-analysed the LSS data. In an excess rela-
tive risk model, standard dependences on age-at-exposure,
e, and attained age, a, were applied for those not partici-
pating in the AHS programme, while for LSS members
participating in the AHS, the baseline thyroid cancer
incidence rate was modified by a time-dependent screening
factor FAHS(a,e), having different values before and after
1970:
These two time periods were chosen to differentiate the
early period with many autopsies from the later period with
fewer autopsies (Preston et al. 2007). More details on the
risk models and their parameters are given in the Electronic
Supplementary Material.
Excess absolute rate in the Fukushima Prefecture
The standard approach of transferring risk estimates for
thyroid cancer in the LSS to other populations is
assuming a multiplicative interaction of radiation and
other risk factors, i.e. the excess relative risk per unit
dose (ERR) is assumed to be the same in both popula-
tions (US Environmental Protection Agency 2011;
National Research Council 2006). Thus, the excess
absolute rate per unit dose in the population of interest,
EAR, is obtained by multiplication of ERR with the
country-specific incidence rate. For the present study,
three additional factors were applied: Fscr (see above),
FL(a–e) that takes into account that radiation-induced
cases are not expected before 3 years after the exposure
(Heidenreich et al. 1999) and FDREF for the additional
uncertainty of the risk function at low dose rate (Jacob
et al. 2009). In summary, we calculate in the model of
multiplicative interaction
EAR s; e; að Þ ¼ FscrFL a  eð ÞFDREFERRLSS s; e; að ÞkJapan s; að Þ;
ð4Þ
where ERRLSS(s,e,a) is the excess relative risk per unit
dose for LSS cohort members not participating in the AHS,
where s is an indicator for sex.
Baseline thyroid cancer incidence rate in Japan in 2007
is lower than 10-6 per year for males of age younger than
15 years, which is reported as zero in the Japanese cancer
centre (National Cancer Center 2012). Based on these data
and according to Eq. (4), no cases would be expected
during the first 15 years among males exposed as infants.
In order to avoid this artefact, an equal probability of any
FAHSða; eÞ ¼ expðbAHS;1Þ; if a  e 25 (member of AHS in 1970 and later)expðbAHS;1 þ bAHS;2Þ; otherwise (member of AHS before 1970)

ð3Þ
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risk between results obtained with models of additive and
multiplicative interactions (mixed transfer) is assumed:
EAR s; e; að Þ ¼ FscrFL a  eð ÞFDREFERRLSS s; e; að Þ
 f kJapan s; að Þ þ 1  fð ÞkLSS s; e; að Þ
 
ð5Þ
where f is assumed to be uniformly distributed between 0
and 1. Similarly, WHO (2013) used weighted average of
multiplicative and additive risk transfer, assuming equal
weights.
Attributable risk
The risk rate attributable to radiation exposure, ARR, is
calculated in Eq. 6 by multiplication of EAR(s,e,a) with
thyroid dose, D, and taking into account cancer-free sur-
vival, S(s,a), in Japan in 2007 (National Cancer Center
2012; Ministry of Health, Labour and Welfare of Japan
2013; see also Electronic Supplementary Material):
ARR s; e; a; Dð Þ ¼ EAR s; e; að Þ D S s; að Þ=S s; eð Þ ð6Þ
Attributable risks are then obtained by integration over
pre-defined periods after exposure:
ARðs; e; a; DÞ ¼
Za
e
ARRðs; e; t; DÞdt ð7Þ
Lifetime attributable risk refers to an integration period
from exposure over the whole lifetime.
Similarly, baseline risk is modelled as follows (Eq. 8):
BRðs; e; aÞ ¼ Fscr
Za
e
kJapanðs; tÞSðs; tÞdt=Sðs; eÞ: ð8Þ
Risks for the study group are calculated by averaging
over the sex–age distribution at the time of exposure.
Results
Thyroid cancer prevalence
Our estimate of prevalence of pathologically confirmed
thyroid cancer cases among the screened population of the
municipalities in the Fukushima Prefecture targeted for the
survey for the period October 2011 to March 2012 is 0.027
% (95 % CI 0.010 %; 0.050) (Table 1). The large uncer-
tainty of this estimation is mainly caused by the uncer-
tainties of the prevalence of baseline cases in the UkrAm
cohort, PUA, and of the impact of differences of the study
protocol, expressed by the factor, fsp.
Prevalence for the municipalities of the Fukushima
Prefecture targeted for later periods is predicted to be
somewhat higher, because the screening has been per-
formed later; thus, mean age in the cohort at the time of
screening and, correspondingly, average hypothetical
incidence rate without screening are higher (see
Table 1).
Table 1 Expected prevalence of confirmed thyroid cancer among
screened population groups targeted for the Fukushima Health
Management Survey before April 2012, for the period from April
2012 to March 2013, and in the non-contaminated prefectures of
Aomori, Yamanashi and Nagasaki (Taniguchi et al. 2013). Hypo-
thetical thyroid cancer incidence rate without screening according to



































a Arithmetic mean and 95 % confidence interval
Fig. 1 Increase in thyroid cancer incidence rate due to ultrasonog-
raphy screening. The upper two studies relate to populations without
systematic screening; thus, the estimates of the effect of ‘grey’
screening on these populations (left border of the boxes) are lower
boundaries for the effect of a systematic screening. The screening
factor for the Fukushima Prefecture, Fscr, is the product of the
screening factor in the UkrAm cohort, fUA, and a factor taking into
account differences in the study protocol, fsp
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Screening factors due to ultrasonography surveys
Thyroid cancer incidence rate in the UkrAm cohort during
the second to fourth screening is estimated to be higher
than the national incidence rate in Ukraine by a factor, fUA,
of 3.6, with a 95 % confidence range from 0.5 to 7.9
(Fig. 1).
Thyroid cancer incidence rate in the Fukushima Pre-
fecture under the condition of continued ultrasonography
surveys is estimated to be increased compared with the
incidence rate in 2007 by a factor of 7.4, with a 95 %
confidence range from 0.96 to 17.3. Because of differences
in the study protocol, the screening factor in the Fukushima
Prefecture is larger and has a wider confidence interval
than that in the UkrAm cohort.
Thyroid cancer incidence risk in the LSS
The impact of screening and autopsies on thyroid cancer
incidence among AHS participants was relatively small.
For the period before 1970 with a relatively high rate of
autopsies, we find a screening factor of 1.72 (95 % CI 1.17;
2.55), and for the period afterwards of 1.23 (95 % CI 0.96;
1.59).
ERR in the LSS decreases with age at exposure and age
attained (see Fig. 2). EAR decreases with age at exposure
as well. However, it increases with time since exposure.
Attributable risk rate
In the mixed transfer model, the risk rate attributable to
radiation exposure increases for young ages at exposure
after the minimal latency period of 3 years for a few years
steeply with time since exposure (Fig. 3), while it contin-
ues to increase with a smaller slope for the next 50 years.
For example, for an exposure of females at age of 1 year
with a thyroid dose of 100 mSv, the attributable risk rate is
predicted to increase from about 0.2 cases per 104 person-
years at an attained age of 10 years to 6 cases per 104
person-years at an attained age 50 years.
For exposure at older age, the increase is less steep. The
attributable risk rate reaches a flat maximum at the attained
age of about 60 years and decreases subsequently due to
the decrease in the survival function.
Fig. 2 Excess relative risk (upper panels) and excess absolute rate (lower panels) of thyroid cancer of male (left panels, blue curves) and female
(right panels, red curves) LSS members not participating in the AHS for different ages at exposure (shown as numbers in years near the curves)
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In general, best estimates of the attributable risk rate for
females are larger than those for males. The ratio is max-
imal for an attained age of about 40 years with a value of
5.5 for age at exposure of 1 year. The difference is, how-
ever, not significant due to the large uncertainty of the
estimates. Main sources of uncertainty are the risk function
derived from the LSS, the screening factor, and extrapo-
lation of the risk function to low dose rates (in the order of
decreasing importance).
With the exception of young attained age, the multi-
plicative transfer, Eq. (4), gives results very similar to the
mixed transfer. For boys below attained age of 15 years
and girls below age of 10, the multiplicative transfer results
in no excess cases, whereas the mixed transfer gives non-
zero results.
Attributable risk
Most of the long-term attributable risk accumulates over
several decades, whereas the risk during the first years after
exposure is small (Table 2). The contribution of the first
10 years to the risk over 50 years decreases with increasing
age at exposure. The long latency is especially expressed
for females: for age at exposure of 1 year, less than 1 % of
the attributable risk cumulated during 50 years after
exposure (for 100 mSv: 1.4 %) is contributed by the first
10 years (0.013 %).
For the same thyroid dose, the attributable risk accu-
mulating over several decades after exposure decreases
with increasing age at exposure. However, the effect is
relatively modest (about a factor of two for ages at expo-
sure of 1 and 18 years).
Under the condition of continued screening, baseline
thyroid cancer risk during the first 50 years after exposure
in the screened population of the Fukushima Prefecture is
predicted to be 2.2 (95 % CI 0.27; 5.3) % (Table 3). For an
average thyroid dose of 20 mSv, the risk related to the
radiation exposure amounts to 0.13 (95 % CI 0.005;
0.40) %. Less than 5 % of the radiation-related risk accu-
mulates during the first 10 years after the exposure.
Discussion
Thyroid cancer prevalence
The first ultrasonography survey in the Fukushima Pre-
fecture is intended to be finished at 31 Mar 2014, about
3 years after the accident at Fukushima Dai-ichi NPS.
After the Chernobyl accident, an excess of thyroid cancer
cases was not observed before 3 years after exposure
(Heidenreich et al. 1999). Thus, the prevalent cases in the
Fukushima Prefecture are not assumed to be related to
radiation exposure.
As of 31 July 2013, surgery of the thyroid has been
performed for ten persons out of 41,296 who lived at the
Fig. 3 Mixed transfer model for the attributable risk rate of thyroid
cancer after exposure at age of 1, 10, and 18 years with a thyroid dose
of 100 mGy. Mean values and 95 % confidence intervals are shown
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time of the accident in 13 municipalities that were targeted
for ultrasonography survey before April 2012 (Fukushima
Medical University 2013a). Nine of the cases were papil-
lary carcinoma, one turned out to be a benign nodule. This
corresponds to a prevalence of confirmed cases of
9/41,296 = 0.022 %. This number is a lower boundary for
the prevalence because
• four persons having suspected malignancy according to
cytology of FNA biopsies had not been operated before
31 July 2013;
• only 165 out of 214 individuals, for whom secondary
examination was required, have finished such an
examination.
Thus, the results obtained so far by the survey are in
agreement with our calculations that resulted in a preva-
lence of 0.027 (0.010; 0.050) % (Table 1).
Screening factors in post-Chernobyl studies
In a population-based study of Likhtarov et al. (2006),
population groups with ultrasonography frequency of more
than 1.8 % and less than 0.7 % have been compared. They
estimated thyroid cancer incidence rate in the former group
to be larger by a factor of 3.3 than in the latter. For
Ukrainian oblasts with high thyroid exposures due to the
Chernobyl accident and for most oblasts in Belarus, base-
line thyroid cancer incidence in 1999 compared with 1988
was assessed to be higher by a factor of about three (Jacob
et al. 2006a). This effect was attributed to an increased
surveillance of the thyroid. The present result of the
screening factor in the UkrAm cohort of 3.6 (95 % CI 0.5;
7.9) is consistent with the assessment of the two popula-
tion-based studies mentioned above.
Thyroid cancer risk in atomic bomb survivors
versus post-Chernobyl studies
The excess relative risk for thyroid cancer after exposure
during childhood with a thyroid dose of 1 Sv in the LSS
compares generally well to study results of populations
exposed to 131I after the Chernobyl accident (Fig. 4, upper
panel). For times after exposure of less than 13 years, i.e.
when collection of incidence data in the LSS was not yet
performed, it cannot be excluded that excess relative risks
after exposure at young age are larger than those based on
Table 2 Baseline and radiation-attributable thyroid cancer risk (mean value and 95 % confidence interval) after an exposure with a hypothetical
thyroid dose of 100 mSv for different time periods after exposure
Age at exposure
(years)
Sex Thyroid cancer Thyroid cancer risk (%) for different periods after exposure with a thyroid dose of 100 mSv
10 years 20 years 50 years
1 Male Baseline 0.0 (0.0; 0.0) 0.026 (0.003; 0.065) 0.52 (0.06; 1.2)
Attributable 0.014 (\10-4; 0.090) 0.054 (0.002; 0.26) 0.30 (0.015; 1.2)
Female Baseline 0.0029 (2 9 10-4; 0.0088) 0.089 (0.012; 0.22) 2.3 (0.31; 5.5)
Attributable 0.013 (3 9 10-4; 0.069) 0.12 (0.007; 0.51) 1.4 (0.11; 4.6)
10 Male Baseline 0.021 (0.003; 0.053) 0.11 (0.015; 0.27) 0.91 (0.12; 2.2)
Attributable 0.019 (6 9 10-4; 0.088) 0.059 (0.003; 0.24) 0.24 (0.013; 0.87)
Female Baseline 0.071 (0.008; 0.18) 0.33 (0.04; 0.80) 3.6 (0.44; 8.7)
Attributable 0.042 (0.002; 0.19) 0.16 (0.008; 0.59) 0.94 (0.058; 3.1)
18 Male Baseline 0.080 (0.010; 0.20) 0.20 (0.026; 0.50) 1.2 (0.16; 3.0)
Attributable 0.018 (7 9 10-4; 0.077) 0.047 (0.002; 0.19) 0.18 (0.009; 0.64)
Female Baseline 0.22 (0.026; 0.52) 0.79 (0.091; 1.8) 4.7 (0.54; 11)
Attributable 0.044 (0.002; 0.17) 0.15 (0.007; 0.55) 0.63 (0.03; 2.0)
Table 3 Predicted thyroid cancer risk (mean and 95 % confidence interval) in the Fukushima Prefecture: baseline and attributable to radiation
exposure for thyroid doses of 50 and 20 mSv assumed for the most exposed population groups
Average thyroid
dose (mSv)
Thyroid cancer Thyroid cancer risk (%) for different periods after exposure
10 years 20 years 50 years
– Baseline 0.055 (0.006; 0.14) 0.23 (0.027; 0.58) 2.2 (0.27; 5.3)
20 Attributable 0.0057 (0.0002; 0.025) 0.021 (0.0007; 0.081) 0.13 (0.005; 0.40)
50 Attributable 0.014 (0.0004; 0.063) 0.053 (0.002; 0.20) 0.32 (0.011; 1.0)
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the extrapolation of the LSS function. This would have,
however, negligible implications for our results on attrib-
utable risk, because the baseline risk in Japan in 2007 for
age below 20 years is very small and because there is a
good agreement of the excess absolute rate results (see
below).
The excess absolute rate depends on the screening
conditions. It is relatively small for the LSS members not
participating in the AHS (Fig. 4, lower panel, blue dashed
line). Applying the full screening factor, Fscr, leads to an
EAR estimate (Fig. 4, lower panel, blue solid line) that
tends to be higher than what was observed in the UkrAm
cohort. This is plausible, because the study protocol in the
Fukushima Prefecture is expected to lead to a higher
screening effect than in the UkrAm cohort. Indeed, if the
screening factor for the UkrAm cohort fUA is applied to
EARLSS, then good agreement with the excess absolute rate
per unit dose in the UkrAm cohort is obtained (curve not
depicted in Fig. 4).
Overall, these comparisons do not give any evidence
against the application of the LSS risk function and the
screening factor Fscr to populations screened in the Fuku-
shima Prefecture.
Attributable risk rate
In our approach with a mixed transfer of excess risk esti-
mates from the LSS to the population in the Fukushima
Prefecture, the attributable risk rate increases steeply after
a minimal latency period of 3 years. In contrast, according
to the multiplicative transfer, excess cases do not appear
before attained age of 15 for males and age attained 10 for
females. The latter approach is not in accordance with
experiences after the Chernobyl accident, however, where
many excess cases were observed before attained age of
10 years (UNSCEAR 2011).
Attributable risk
According to the results shown in Table 2 for an age of
exposure of 1 year, about 15 % of the attributable risk
accumulated over 20 years is contributed by the first
10 years after exposure. For an age of exposure of
10 years, we obtain a contribution of 30 %. These pre-
dictions compare well to thyroid cancer incidence after the
Chernobyl accident. In Belarus, for example, where most
of the observed thyroid cancer incidence was attributed to
radiation exposure (Jacob et al. 2006a), 29 % of thyroid
cancer cases during the first 20 years after exposure
occurred during the first 10 years for the age-at-exposure
group of 0–4 years, and 35 % for the age-at-exposure
group of 5–9 years (UNSCEAR 2011).
Another check of consistency with post-Chernobyl
experiences relates to age-at-exposure dependence.
According to our prediction, the attributable risk accumu-
lated over the first 20 years after exposure is about the
same for ages at exposure of 1 and 10 years, if the thyroid
dose is the same. In Belarus, the number of cases was
higher for the age-at-exposure group of 0–4 years than for
the age-at-exposure group of 5–9 years by a factor of 1.7
(UNSCEAR 2011). Thyroid doses differed by a similar
factor (Jacob et al. 2006a).
Finally, we predict the excess rate during the first
20 years after exposure among females to be higher than
among males by a factor of 2–3. Again, in Belarus, the risk
was higher by a factor of 2.6 (crude rate among females of
6.7 versus 2.6 per 104 person-years for males, according to
UNSCEAR (2011)).
Fig. 4 Sex-averaged relative risk (upper panel) and excess absolute
rate (lower panel) of thyroid cancer after an exposure at an age of 7 years
(average age at exposure in post-Chernobyl cohort and case–control
studies). Error bars and shaded areas indicate 95 % confidence regions.
Results for the LSS members not participating in the AHS with and
without the screening factor Fscr are presented in blue, results from post-
Chernobyl studies are presented in red and by symbols
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Whereas our predictions for the first 20 years after
exposure are supported by some studies of thyroid cancer
after the Chernobyl accident, our longer-time predictions
are more uncertain and may overestimate the risk. This is
so because we have neglected a so-called harvesting effect
that might appear after 20 years after exposure: Early
detection may lead to lower numbers of detected cases at
later campaigns of a survey. However, we are not aware of
studies that give evidence of a harvesting effect of ultra-
sonography for thyroid cancer incidence.
For a period of 50 years after exposure at ages at
exposure of up to 18 years, we predict that an average
thyroid dose of 20 mSv would result in a relative contri-
bution of about 6 % to the total thyroid cancer risk. This is
in accordance with the results of WHO (2013), because of
the close similarity of the approaches applied concerning
relative risks. Concerning the total thyroid cancer risk,
however, our results are higher by a factor of about 7,
because WHO did not consider in its calculations the
impact of the ultrasonography survey.
Conclusion
Based on the results presented here, it is expected that the
ultrasonography survey of residents of Fukushima Prefec-
ture will increase thyroid cancer incidence compared with
thyroid cancer incidence in 2007 in Japan drastically. The
estimated increase has a large uncertainty with a best
estimate of a factor of about 7. For an average thyroid dose
of 20 mSv of the most exposed in the surveyed population,
it is estimated that in the early period, about 10 % and in
later periods about 5 % of the reported incidence will be
attributable to radiation exposure. Thus, the fraction of
thyroid cancer cases attributable to radiation exposure will
be small, although there are regional differences due to
varying doses. The present assessment includes large
uncertainties caused by uncertainties in the thyroid cancer
risk function for the LSS, the impact of the ultrasonography
survey, and the transfer of the risk function to low-dose
exposures to 131I. Independent of these uncertainties,
however, the order of magnitude of the predicted thyroid
cancer prevalence and incidence rate may help to be pre-
pared for a relatively large number of thyroid cancer cases
that are to be expected. It is emphasized that most of the
cases would not have become clinically relevant without
the ultrasonography survey.
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